Literature DB >> 7518836

Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.

F Brière1, J M Bridon, D Chevet, G Souillet, F Bienvenu, C Guret, H Martinez-Valdez, J Banchereau.   

Abstract

We have previously shown that human B lymphocytes cultured in the CD40 system, composed of an anti-CD40 mAb presented by a CD32-transfected fibroblastic cell line, proliferate but do not secrete antibodies. However, the addition of particles of Staphylococcus aureus Cowan (SAC) induces B cell differentiation even in the absence of exogenous cytokines (CD40/SAC system). Additionally, B lymphocytes cultured in the CD40 system in the presence of human IL-10, produce IgM, IgG, and IgA, and Ig levels are further increased by SAC. Here, we have studied the capacity of peripheral blood lymphocytes from patients with IgA deficiency (IgA-D) to secrete Igs, particularly IgA after CD40 triggering. Peripheral blood mononuclear cells (PBMNC) from IgA-D patients cultured in the CD40/SAC system produced IgM and IgG, but not IgA. The addition of IL-10 to the cultures, enhanced the production of IgM and IgG and most strikingly induced the production of high amounts of IgA. The addition of IL-10 to PBMNC from IgA-D patients activated through CD40 alone resulted in the production of IgA. Thus, SAC and anti-CD40 mAb stimulate B cells to differentiate into cells secreting IgG and IgM whereas IL-10 plays a central role in inducing B cells from IgA-D patients to differentiate into IgA secreting cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518836      PMCID: PMC296286          DOI: 10.1172/JCI117354

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency.

Authors:  T A Waldmann; S Broder; R Krakauer; M Durm; B Meade; C Goldman
Journal:  Trans Assoc Am Physicians       Date:  1976

2.  Epitope mapping of recombinant human gamma interferon using monoclonal antibodies.

Authors:  C Favre; J Wijdenes; H Cabrillat; O Djossou; J Banchereau; J E de Vries
Journal:  Mol Immunol       Date:  1989-01       Impact factor: 4.407

3.  Antibodies to alpha-interferon in a patient with systemic lupus erythematosus.

Authors:  S Panem; I J Check; D Henriksen; J Vilcek
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

4.  Selective IgA deficiency: analysis of Ig production in vitro.

Authors:  T Inoue; H Okubo; J Kudo; T Ikuta; K Hachimine; R Shibata; O Yoshinari; K Fukada; T Yanase
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

5.  Immature IgA B cells in IgA-deficient patients.

Authors:  M E Conley; M D Cooper
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

6.  B cell growth-promoting activity of recombinant human interleukin 4.

Authors:  T Defrance; B Vanbervliet; J P Aubry; Y Takebe; N Arai; A Miyajima; T Yokota; F Lee; K Arai; J E de Vries
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

7.  Evidence for the failure of IgA specific T helper activity in a patient with immunodeficiency with hyper IgM.

Authors:  H Mitsuya; S Tomino; S Hisamitsu; S Kishimoto
Journal:  J Clin Lab Immunol       Date:  1979-11

8.  Family studies of IgA deficiency.

Authors:  A N Wilton; T J Cobain; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation.

Authors:  G A Peltz; M L Trounstine; K W Moore
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

10.  [Reconstitution of immunoglobulin production in patients with variable immunodeficiency syndrome (CVI) by the CD40 system and IL-10].

Authors:  S Zielen; P Sehrt; J Rahmig; D Hofmann; F Brière; S C Meuer
Journal:  Immun Infekt       Date:  1994-02
View more
  26 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

2.  Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.

Authors:  Zaheed Husain; Nichol Holodick; Caitlin Day; Irma Szymanski; Chester A Alper
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

3.  Effects of arginine supplementation on splenocyte cytokine mRNA expression in rats with gut-derived sepsis.

Authors:  Huey-Fang Shang; Chun-Sen Hsu; Chiu-Li Yeh; Man-Hui Pai; Sung-Ling Yeh
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

4.  IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients.

Authors:  M Marconi; A Plebani; M A Avanzini; R Maccario; A Pistorio; M Duse; M Stringa; V Monafo
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

5.  Central importance of immunoglobulin A in host defense against Giardia spp.

Authors:  T Dianne Langford; Michael P Housley; Marianne Boes; Jianzhu Chen; Martin F Kagnoff; Frances D Gillin; Lars Eckmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Role for Msh5 in the regulation of Ig class switch recombination.

Authors:  Hideharu Sekine; Ricardo C Ferreira; Qiang Pan-Hammarström; Robert R Graham; Beth Ziemba; Sandra S de Vries; Jiabin Liu; Keli Hippen; Thearith Koeuth; Ward Ortmann; Akiko Iwahori; Margaret K Elliott; Steven Offer; Cara Skon; Likun Du; Jill Novitzke; Annette T Lee; Nianxi Zhao; Joshua D Tompkins; David Altshuler; Peter K Gregersen; Charlotte Cunningham-Rundles; Reuben S Harris; Chengtao Her; David L Nelson; Lennart Hammarström; Gary S Gilkeson; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-04       Impact factor: 11.205

7.  BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.

Authors:  Danielle T Avery; Susan L Kalled; Julia I Ellyard; Christine Ambrose; Sarah A Bixler; Marilyn Thien; Robert Brink; Fabienne Mackay; Philip D Hodgkin; Stuart G Tangye
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk.

Authors:  Aaron A Reeves; Marney C Johnson; Margarita M Vasquez; Akhil Maheshwari; Cynthia L Blanco
Journal:  Breastfeed Med       Date:  2013-07-19       Impact factor: 1.817

9.  Synergistic augmentative effect of interleukin-10 and CD27/CD70 interactions on B-cell immunoglobulin synthesis.

Authors:  H Nagumo; K Agematsu
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

Review 10.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.